Seroba Life Sciences Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 6
- Investments
- 53
- Portfolio
- 10
- Exits
- 19
Seroba Life Sciences General Information
Description
Founded in 2009, Seroba Life Sciences is a venture capital firm based in Dublin, Ireland. The firm seeks to invest in the healthcare sector.
Contact Information
Website
Year Founded
2009
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- 18 Herbert Street
- Dublin D02 FK19
- Ireland
+353 (01) 000 0000
Seroba Life Sciences Investments (53)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Shorla Pharma | 02-Jun-2020 | Early Stage VC | 00.000 | Drug Discovery | Product Development | 0000 0'0000000 00.0 |
| 0000000000 | 24-Sep-2019 | 00000 00000 | 0000 | Monitoring Equipment | Generating Revenue | 00000000 0000000 |
| 000000 00000000 00 | 29-Jul-2019 | 00000 00000 | 0000 | Therapeutic Devices | Generating Revenue | 00000 000000 |
| 00000 000000000000 | 20-May-2019 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | 00000 000000000 00.0 |
| 000000 00000000000 | 25-Mar-2019 | 00000 00000 | 00000 | Drug Discovery | Clinical Trials - Phase 1 | 0000 0'0000000 00.0 |
| 00 000000 | 14-Jan-2019 | 00000 00000 | 0000 | Surgical Devices | Generating Revenue | 000000 0'000000 00.0 |
| 00000000 000000000 | 07-Jan-2019 | 00000 00000 | 000.00 | Therapeutic Devices | Generating Revenue | 000000 0'000000 00.0 |
| 000000 00000000000 | 26-Aug-2018 | 00000 00000 | 00.000 | Drug Discovery | Bankruptcy: Liquidation | 0000 0'0000000 00.0 |
| Endotronix | 12-Feb-2018 | Later Stage VC | 0000 | Monitoring Equipment | Generating Revenue | 00000000 0000000 |
| Labcyte | 01-Nov-2017 | Later Stage VC | 000 | Other Healthcare Technology Systems | Generating Revenue |
Seroba Life Sciences Exits (19)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Fusion Pharmaceuticals | 26-Jun-2020 | IPO | 00000 |
| 0000000000000000 0 | 26-Jun-2020 | 000000000000000000 | 000.00 |
| 0000 000000 | 01-Oct-2019 | 000 00 00000000 | |
| 0000000 | 30-Jan-2019 | 000000000000000000 | |
| 000000 00000000000 | 13-Jan-2019 | 0000000000: 000000 | |
| 000000 | 13-Dec-2018 | 000000000000000000 | |
| 000000 0000000 000 | 07-Sep-2018 | 000000000000000000 | 00000 |
| 000000000 | 13-Jul-2018 | 000000000000000000 | |
| Prexton Therapeutics | 16-Mar-2018 | Merger/Acquisition | 00000 |
| Heart Metabolics | 01-Nov-2017 | Out of Business |
Seroba Life Sciences Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialSeroba Life Sciences Team (10)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Alan O'Connell Ph.D | Partner | 00 | 0 | 0 | Dublin, Ireland |
| Daniel O'Mahony Ph.D | Partner | 00 | 0 | 0 | Dublin, Ireland |
| Andrew Duignan | Chief Financial Officer | Dublin, Ireland | |||
| Peter Sandys | Co-Founder & Managing Partner | 0 | 0 | 0 | Dublin, Ireland |
| Jennifer McMahon | Principal | 0 | 0 | 0 | Dublin, Ireland |
Seroba Life Sciences Co-Investors (54)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Andera Partners | 2 | 0 |
|
|
|
| IP Group | 0 | 0 | 0 |
|
|
| Life Sciences Partners | 0 | 0 |
|
|
|
| M Ventures | 0 | 0 | 0 |
|
|
| Ysios Capital | 0 | 0 | 0 |
|
|